About the Conference

IBC’s 3rd Pharma Market Access 2017 conference focuses on profitable yet patient-centric market access strategies for Asia’s diverse markets, examining pricing and reimbursement regulations in each market. A review of healthcare economics, policies, different business models, and an understanding of the dynamics of each market will accessed.

This event is a single platform convening pharma and industry experts to navigate the complex environments and lessons learnt from successful and profitable market entries for orphan drugs, high priced therapeutics, generics, biosimilars and more.


“Very insightful to be having heard from the speakers. Glad to be here and hope to be here again next year. The conference is unique as it discusses patient support.”
Kenneth Mah, Vice President, Rare Disorder Society

Top 5 Reasons To Attend

  • GAIN insight from government’s views and direction towards pharma market access
  • EXPLORE more patient-centric approaches and access strategies
  • NEW THINKING on pricing and reimbursement through global and regional case studies
  • ASSESS growth markets and develop strategies for them
  • NETWORK with participants across the 3 events


PharmaCon Asia At a Glance